Johnson & Johnson will buy cardiovascular technology company Abiomed for $16.6 billion to strengthen its medical device division. This…
Johnson & Johnson will buy cardiovascular technology company Abiomed for $16.6 billion to strengthen its medical device division.
The healthcare giant said Tuesday that it will pay $380 per share of Biomed and provide $35 per share in cash if certain commercial and clinical milestones are met.
Abiomed develops technologies to treat coronary artery disease and heart failure.
Copyright © 2022 The Associated Press. all rights reserved. This material may not be published, broadcast, written or redistributed.
Like WTOP on Facebook and follow WTOP on Twitter Join the conversation about this and other articles with Instagram.
Get breaking news and daily top stories delivered to your email inbox by signing up here.
© 2022 WTO. all rights reserved. This website is not intended for users located in the European Economic Area.